Skip Navigation

Press Releases

Filter Press Releases

August 28, 1996

NHLBI Scientists Find Link Between Common Virus and Restenosis

Scientists with the National Heart, Lung, and Blood Institute (NHLBI) have found a strong link between prior infection with cytomegalovirus (CMV) and restenosis--the renarrowing of coronary arteries that commonly occurs after coronary angioplasty.

August 7, 1996

Bone Marrow Transplantation Can Provide Cure for Sickle Cell

The first multi-center study of bone marrow transplantation in children with sickle cell disease has demonstrated that this procedure can provide a cure for young sickle cell patients who have a matched sibling, researchers supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health reported today.

June 26, 1996

NHLBI Study Reports Improved Blood Safety

The risk that a patient will be given blood that is infected with HIV, the virus that causes AIDS, is less than 2 cases per million units transfused, according to researchers participating in the National Heart, Lung, and Blood Institute's (NHLBI) Retrovirus Epidemiology Donor Study (REDS).

May 21, 1996

NHLBI Studies Underscore Need for Early, Aggressive

The May 22, 1996, issue of the Journal of the American Medical Association spotlights the problem of high blood pressure management, as well as new clues into its development and related conditions. Many of these studies were supported by the NHLBI.

February 26, 1996

NHLBI Researchers Grow Lung Tissue in Animals

Scientists supported by the National Heart, Lung, and Blood Institute (NHLBI) have been able to grow new tissue in the lungs of laboratory animals for the first time.

September 21, 1995

Bypass Surgery Results in Lower Death Rates for Diabetic

Patients on drug treatment for diabetes who had blockages in two or more coronary arteries and were treated with coronary artery bypass surgery (CABG) had at 5 years a markedly lower death rate than similar patients treated with angioplasty, announced the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health as it released findings from a major clinical trial and issued an alert to U.S. physicians.

August 30, 1995

NHLBI Panel Reviews Safety of Calcium Channel Blockers

Short-acting nifedipine, a type of calcium channel blocker prescribed for hypertension and certain heart disorders, should be used with "great caution (if at all)," especially at higher doses, concludes the National Heart, Lung, and Blood Institute in a statement for health professionals.

Page 63 of 63

Pages

Subscribe to NHLBI Press Releases